Clinical Study
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis
Table 2
Dietary intake and absorption in the mITT population ().
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
All values expressed as mean ± 1 standard deviation (range). Mean treatment difference determined from within-patient differences. CFA: coefficient of fat absorption; CAN: coefficient of nitrogen absorption; mITT: modified Intent-To-Treat (patients completing both treatment periods). |